Abstract
Purpose
Self-reported taste alterations are common in people receiving chemotherapy; however, it is usually unclear whether these reports refer to changes to the sense of taste itself or to problems related to the broader phenomenon of flavour, or the hedonic experience of eating and drinking. The purpose of this study was to explore patient and carer descriptions, experiences and consequences of taste and flavour changes associated with oxaliplatin treatment.
Methods
This study utilised a grounded theory research design. Purposeful sampling was used to recruit eligible patients who had self-reported taste changes in relation to oxaliplatin-containing chemotherapy for colorectal cancer. Content analysis of interview data was performed using an analysis framework derived from previous sensory and nutritional sciences and supportive care research.
Results
Ten patients and four carers participated in semi-structured interviews. The overarching theme identified from the data was reduced food enjoyment. In addition to changes to taste, participants described sensory and hedonic changes which influence overall flavour perception and food enjoyment. Reduced food enjoyment had dietary, social and emotional consequences for patients and carers.
Conclusions
‘Taste’ problems during oxaliplatin treatment mostly relate to the broader phenomena of flavour. This study has helped to unravel the major sensory determinants of the eating and drinking experience in the chemotherapy setting and has provided guidance regarding relevant and measurable endpoints of chemotherapy-related flavour changes. There remains a gap in knowledge between the pattern of flavour changes associated with chemotherapy treatment and how this influences dietary intake and nutritional status.
Similar content being viewed by others
References
Hovan A, Williams P, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18(8):1081–1087
Zabernigg A, Gamper E, Giesinger J et al (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 15(8):913–920
Boltong A, Keast R, Aranda S (2011) Talking about taste: how do oncology clinicians discuss and document taste problems? Cancer Forum 35(2):81–87
Bartoshuk LM (1990) Chemosensory alterations and cancer therapies. J Natl Cancer Inst Monogr 9:179–184
Breslin P, Spector A (2008) Mammalian taste perception. Curr Biol 18(4):R148–R155
Keast R (2004) Flavor interactions at the sensory level. In: Taylor A, Roberts D (eds) Flavor Perception. Blackwell Publishing, United Kingdom, pp 228–254
Delwiche J (2004) The impact of perceptual interactions on perceived flavor. Food Qual Prefer 15(2):137–146
Prescott J (1999) Flavour as a psychological construct: implications for perceiving and measuring the sensory qualities of foods. Food Qual Prefer 10(4–5):349–356
Kahneman D, Diener E, Shwarz N (2003) Well-being: the foundations of hedonic psychology. Russell Sage, New York
McQuestion M, Fitch M, Howell D (2011) The changed meaning of food: physical, social and emotional loss for patients having received radiation treatment for head and neck cancer. Eur J Oncol Nurs 15(2):145–151
Boltong A, Keast R (2012) The influence of chemotherapy on basic taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163
Wickham R, Rewahldt M, Kefer C et al (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26(4):697–706
Eichhorst B, Busch R, Obwandner T et al (2007) Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. J Clin Oncol 25(13):1722–1731
Greimel E, Bjelic-Radisic V, Pfisterer J et al (2006) Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel. J Clin Oncol 24(4):579–586
Gridelli C, Gallo C, Shepherd F et al (2003) Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21(16):3025–3034
Hurny C, Berhard J, Coates A et al (1996) Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. Lancet 347(9011):1279–1284
Strauss A, Corbin J (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, California
Halcomb E, Davidson P (2006) Is verbatim transcription of interview data always necessary? Appl Nurs Res 19(1):38–42
Eaves Y (2001) A synthesis technique for grounded theory data analysis. J Adv Nurs 35(5):654–663
Bernhardson B, Tishelman C, Rutqvist L (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage 34(4):403–412
Duffy V, Fast K, Lucchina L, Bartoshuk L (2002) Oral sensation and cancer. In: Berger A, Portenoy R, Weissman D (eds) Principles and practice of palliative care and supportive oncology. LWW, Philadelphia, pp 178–193
Andrykowski M, Otis M (1990) Development of learned food aversions in humans: investigation in a ‘natural laboratory’ of cancer chemotherapy. Appetite 14(2):145–158
Boakes R, Tarrier N, Barnes B, Tattersall M (1993) Prevalence of anticipatory nausea and other side-effects in cancer patients receiving chemotherapy. Eur J Cancer 29A(6):866–870
Holmes S (1993) Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer 1(6):326–330
Jacobsen P, Bovbjerg D, Schwartz M, Andrykowski M (1993) Formation of food aversions in cancer patients receiving repeated infusions of chemotherapy. Behav Res Ther 31(8):739–748
Mattes R, Arnold C, Boraas M (1987) Learned food aversions among cancer chemotherapy patients. Incidence, nature, and clinical implications. Cancer 60(10):2576–2580
Mattes R, Curran W Jr, Alavi J, Powlis W, Whittington R (1992) Clinical implications of learned food aversions in patients with cancer treated with chemotherapy or radiation therapy. Cancer 70(1):192–200
Schwartz M, Jacobsen P, Bovbjerg D (1996) Role of nausea in the development of aversions to a beverage paired with chemotherapy treatment in cancer patients. Physiol Behav 59(4–5):659–663
Melzack R, Torgerson W (1971) On the language of pain. Anesthesiology 34(1):50–59
Acknowledgements
The authors wish to acknowledge the important contribution of all patients and carers who participated in interviews for this study. Thank you to the anonymous reviewers for the time and care taken to review earlier versions of this manuscript.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boltong, A., Keast, R. & Aranda, S. Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 20, 2765–2774 (2012). https://doi.org/10.1007/s00520-012-1398-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1398-7